INmune Bio (INMB)

• Market cap: $44.9M
• 1 day: -1.17%
• 5 days: -6.11%
• 1 month: 4.32%
• 3 months: 27.07%
• 6 months: 8.33%
• Year to date: 9.74%
• 1 year: -46.52%
• 5 years: -89.32%
• 10 years: -78.85%
• Sector: Healthcare
• Industry: Biotechnology

About: INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Employees: 21